Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Li

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Gastroenterology|August 28, 2020
Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative ColitisKatherine Li, Colleen Marano, Hongyan Zhang, et al.
Inflammatory Bowel Diseases|January 7, 2012
Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapyGary Toedter, Katherine Li, Sarah Sague, et al.
Antioxidants & Redox Signaling|November 11, 2023
Isopentyl-Deoxynboquinone Induces Mitochondrial Dysfunction and G2/M Phase Cell Cycle Arrest to Selectively Kill <i>NQO1</i>-Positive Pancreatic Cancer CellsLingxiang Jiang, Yingchun Liu, Soumya Tumbath, et al.
American Journal of Respiratory and Critical Care Medicine|October 22, 2011
Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosisThomas J Richards, Naftali Kaminski, Fred Baribaud, et al.
The Journal of Allergy and Clinical Immunology|April 1, 2014
Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasisHoward Sofen, Stacy Smith, Robert T Matheson, et al.
Ultrasound in Medicine & Biology|July 16, 2013
Quantitative guidelines for the prediction of ultrasound contrast agent destruction during injectionGreg Threlfall, Hong Juan Wu, Katherine Li, et al.
Journal of Crohn'S & Colitis|November 17, 2018
High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel DiseaseAntonio F Di Narzo, Carrie Brodmerkel, Shannon E Telesco, et al.
Plos Genetics|January 28, 2017
High-Throughput Characterization of Blood Serum Proteomics of IBD Patients with Respect to Aging and Genetic FactorsAntonio F Di Narzo, Shannon E Telesco, Carrie Brodmerkel, et al.
BMC Complementary and Alternative Medicine|September 4, 2017
Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasisHui-Man Cheng, Yang-Chang Wu, Qingmin Wang, et al.
Hepatology (Baltimore, Md.)|November 25, 2015
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept studyGideon M Hirschfield, M Eric Gershwin, Richard Strauss, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Gastroenterology|August 28, 2020
Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative ColitisKatherine Li, Colleen Marano, Hongyan Zhang, et al.
Inflammatory Bowel Diseases|January 7, 2012
Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapyGary Toedter, Katherine Li, Sarah Sague, et al.
Antioxidants & Redox Signaling|November 11, 2023
Isopentyl-Deoxynboquinone Induces Mitochondrial Dysfunction and G2/M Phase Cell Cycle Arrest to Selectively Kill <i>NQO1</i>-Positive Pancreatic Cancer CellsLingxiang Jiang, Yingchun Liu, Soumya Tumbath, et al.
American Journal of Respiratory and Critical Care Medicine|October 22, 2011
Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosisThomas J Richards, Naftali Kaminski, Fred Baribaud, et al.
The Journal of Allergy and Clinical Immunology|April 1, 2014
Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasisHoward Sofen, Stacy Smith, Robert T Matheson, et al.
Ultrasound in Medicine & Biology|July 16, 2013
Quantitative guidelines for the prediction of ultrasound contrast agent destruction during injectionGreg Threlfall, Hong Juan Wu, Katherine Li, et al.
Journal of Crohn'S & Colitis|November 17, 2018
High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel DiseaseAntonio F Di Narzo, Carrie Brodmerkel, Shannon E Telesco, et al.
Plos Genetics|January 28, 2017
High-Throughput Characterization of Blood Serum Proteomics of IBD Patients with Respect to Aging and Genetic FactorsAntonio F Di Narzo, Shannon E Telesco, Carrie Brodmerkel, et al.
BMC Complementary and Alternative Medicine|September 4, 2017
Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasisHui-Man Cheng, Yang-Chang Wu, Qingmin Wang, et al.
Hepatology (Baltimore, Md.)|November 25, 2015
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept studyGideon M Hirschfield, M Eric Gershwin, Richard Strauss, et al.
Pageof 8